GM-CLAG in Relapsed/Refractory FLT3-mutated AML

Clinical trial NCT05330377 · WITHDRAWN

Trial details

NCT number: NCT05330377
Sponsor: Ayman H Qasrawi
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2023-03-01
Primary completion: 2027-05-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.